People In Brief
This article was originally published in The Gray Sheet
Executive Summary
AMO promotion: Advanced Medical Optics adds "president" to the title of Chief Operating Officer Richard A. Meier Nov. 19 to reflect increasing management responsibility for the executive. James V. Mazzo shed the president title, but remains CEO and chairman of the eye care device firm. Meier has held the COO spot since February, but relinquished chief financial officer responsibilities in October to new hire Michael J. Lambert. At that time, Meier's management duties expanded to cover AMO's cataract/implant business and global customer service function in addition to his continued oversight of the eye care division and the company's global manufacturing and supply chain operations
You may also be interested in...
Mergers & Acquisitions In Brief
Ecolab's Microtek deal focuses on infection prevention: Acquisition of Microtek Medical for $274 million is intended to expand Ecolab's infection prevention offerings, Ecolab announces Aug. 7. Microtek's surgical drapes, disposable linens, and fluid and medical waste management equipment will dovetail with Ecolab's surface disinfectants, instrument cleaning detergents and surgical hand scrubs. Microtek reported second quarter revenue of $38.5 million, up 6.8%. Ecolab, with Q2 sales of $1.4 billion (up 11%) bills itself as "the world's leading provider of cleaning, food safety and health protection products and services". Ecolab will pay $6.30 in cash for each of Microtek's 43.5 million shares outstanding - representing a 34% premium over Microtek stock's Aug. 7 closing price of $4.69...
CryoCor Plans Launch After Gaining Approval For Cryoablation System
CryoCor plans to begin marketing its cryoablation system for atrial flutter over the next several months, the firm announced Aug. 2
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.